SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000849146-14-000006
Filing Date
2014-02-06
Accepted
2014-02-06 16:03:18
Documents
11
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q lfvn_123113x10q.htm 10-Q 674360
2 CEO CERTIFICATION lfvn_123113xex311.htm EX-31.1 11571
3 CFO CERTIFICATION lfvn_123113xex312.htm EX-31.2 11548
4 CEO CERTIFICATION lfvn_123113xex321.htm EX-32.1 5583
5 CFO CERTIFICATION lfvn_123113xex322.htm EX-32.2 5560
  Complete submission text file 0000849146-14-000006.txt   3617263

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lfvn-20131231.xml EX-101.INS 392896
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20131231.xsd EX-101.SCH 23452
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfvn-20131231_cal.xml EX-101.CAL 53638
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfvn-20131231_def.xml EX-101.DEF 88591
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20131231_lab.xml EX-101.LAB 372868
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20131231_pre.xml EX-101.PRE 200548
Mailing Address 9815 S. MONROE STREET SUITE 100 SANDY UT 84070
Business Address 9815 S. MONROE STREET SUITE 100 SANDY UT 84070 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 841097796 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35647 | Film No.: 14580122
SIC: 2834 Pharmaceutical Preparations